Combs Andrew bought PRLD
February 4, 2026 · Form 4 insider transaction
Combs Andrew bought 230,000 shares of Prelude Therapeutics Incorporated at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
230,000
Price
$0.00
Total value
N/A
InsiderCombs Andrew
RoleOfficer
SecurityEmployee Stock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateFebruary 4, 2026
Filing dateFebruary 5, 2026
Shares owned after230,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The stock option vests as to 25% of the total shares on Feb 4, 2027, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.